Launch HN: Matrubials (YC S21) Milk-derived therapeutics for infectious diseases

Re:Launch HN: Matrubials (YC S21) Milk-derived therapeutics ... by nokcha on Friday July 30, 2021 @02:53PM (#28011079)

Interesting! Are you planning to market your product(s) as a drug, a supplement (or other less-regulated category), or both? (E.g., some fish oil is marketed as a supplement, while other fish oil is marketed as an FDA-approved drug [1].)

>Taken together, our founding team has ~100 years of combined experience in microbiology and ecology, food science and chemistry.

Minor nitpick: Without knowing the size of your team, this sentence is really hard to make sense of. Having 100 people with 1 year of experience each is a lot less impressive than having 10 people with 10 years of experience each.

[1] https://slatestarcodex.com/2014/06/15/fish-now-by-prescripti...

[ Parent | on HN ]

Re:Launch HN: Matrubials (YC S21) Milk-derived therapeutics ... by ishishah on Friday July 30, 2021 @03:14PM (#28011291)

Thank you for your comment. We are evaluating the best path forward based on safety dossier requirements for topical applications. Longer term, we envision that the product should be a prescription based.

Re your comment about founders' experience, we are four founders (three full time Professors, and a senior scientist), with academic and translational portfolio.

[ Parent | on HN ]